Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01708954 |
|---|---|
| Brief Title: | Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer |
| First Submitted : | October 15, 2012 |
| First Submitted that Met QC Criteria : | October 15, 2012 |
| First Posted : | October 17, 2012 (Estimate) |
| Results First Submitted : | October 6, 2016 |
| Results First Submitted that Met QC Criteria : | October 6, 2016 |
| Results First Posted : | December 1, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 15, 2024 |
| Last Update Posted : | May 16, 2024 (Estimate) |